Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Benlahrech, Adel ^a   Gotch, Frances ^a   Kelleher, Peter ^a   Patterson, Steven ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ALPHA; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; LIPOPOLYSACCHARIDE; OLIGODEOXYRIBONUCLEOTIDE;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; INNATE IMMUNITY; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; VIRUS IMMUNITY; ADULT; CELL COUNT; CELL DIFFERENTIATION; COCULTURE; COHORT ANALYSIS; CYTOLOGY; DRUG EFFECT; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SECRETION; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; CELL COUNT; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; COHORT STUDIES; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES; VIREMIA; YOUNG ADULT;

EID: 79952431958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017525     Document Type: Article

References (58)

1. Trinchieri G, (1989) Biology of natural killer cells. Adv Immunol 47: 187-376.
2. Lanier LL, (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8: 259-268.
3. Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, et al. (2003) Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 171: 5663-5667.
4. Fortis C, Biswas P, Soldini L, Veglia F, Careddu AM, et al. (1999) Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis. Eur J Immunol 29: 3654-3662.
5. Kottilil S, (2003) Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infection. Indian J Exp Biol 41: 1219-1225.
6. Bandyopadhyay S, Ziegner U, Campbell DE, Miller DS, Hoxie JA, et al. (1990) Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1. Clin Exp Immunol 79: 430-435.
7. Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I (2009) Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol 182: 1202-1210.
8. Steinman RM, (2003) Some interfaces of dendritic cell biology. APMIS 111: 675-697.
9. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869.
10. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A, (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31: 3388-3393.
11. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, et al. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 31: 2154-2163.
12. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
13. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, et al. (2001) Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 31: 3026-3037.
14. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
15. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, et al. (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5: 405-411.
16. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A, (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
17. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, et al. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195: 327-333.
18. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, et al. (2005) The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174: 727-734.
19. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, et al. (2003) The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33: 306-313.
20. Piccioli D, Sbrana S, Melandri E, Valiante NM, (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195: 335-341.
21. Ferlazzo G, (2005) Natural killer and dendritic cell liaison: recent insights and open questions. Immunol Lett 101: 12-17.
22. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, et al. (1995) Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 182: 789-799.
23. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, et al. (1983) Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 72: 398-403.
24. Douglas SD, Durako SJ, Tustin NB, Houser J, Muenz L, et al. (2001) Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents. AIDS Res Hum Retroviruses 17: 543-552.
25. Kottilil S, Shin K, Planta M, McLaughlin M, Hallahan CW, et al. (2004) Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J Infect Dis 189: 1193-1198.
26. Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, et al. (2001) Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98: 2574-2576.
27. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, et al. (1999) Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 13: 759-766.
28. Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC, (2003) Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 187: 26-37.
29. Donaghy H, Gazzard B, Gotch F, Patterson S, (2003) Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101: 4505-4511.
30. Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, et al. (2009) Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 83: 11175-11187.
31. Reitano KN, Kottilil S, Gille CM, Zhang X, Yan M, et al. (2009) Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res Hum Retroviruses 25: 1029-1037.
32. Alter G, Malenfant JM, Altfeld M, (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.
33. Benlahrech A, Donaghy H, Rozis G, Goodier M, Klavinskis L, et al. (2009) Human NK Cell Up-regulation of CD69, HLA-DR, Interferon gamma Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways. Sensors 9: 386-403.
34. Marshall JD, Heeke DS, Abbate C, Yee P, Van Nest G, (2006) Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha. Immunology 117: 38-46.
35. Amakata Y, Fujiyama Y, Andoh A, Hodohara K, Bamba T, (2001) Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol 124: 214-222.
36. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A, (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6: 769-776.
37. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, et al. (1993) Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 178: 537-547.
38. Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, et al. (2003) Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 207: 85-93.
39. Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, et al. (2004) Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 114: 1612-1623.
40. van der MA, Allebes WA, Paardekooper J, Ruiter J, Joosten I, (2001) HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. Transplantation 72: 923-929.
41. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, et al. (1999) Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94: 333-339.
42. Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, et al. (2002) Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 168: 4796-4801.
43. Kamga I, Kahi S, Develioglu L, Lichtner M, Maranon C, et al. (2005) Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J Infect Dis 192: 303-310.
44. Finke JS, Shodell M, Shah K, Siegal FP, Steinman RM, (2004) Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy. J Clin Immunol 24: 647-652.
45. Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, et al. (2010) Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116: 3839-3852.
46. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200.
47. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, et al. (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115: 3265-3275.
48. Killian MS, Fujimura SH, Hecht FM, Levy JA, (2006) Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. AIDS 20: 1247-1252.
49. Feldman S, Stein D, Amrute S, Denny T, Garcia Z, et al. (2001) Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol 101: 201-210.
50. Pacanowski J, Develioglu L, Kamga I, Sinet M, Desvarieux M, et al. (2004) Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection. J Infect Dis 190: 1889-1892.
51. Siegal FP, Fitzgerald-Bocarsly P, Holland BK, Shodell M, (2001) Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection. AIDS 15: 1603-1612.
52. Azzoni L, Chehimi J, Zhou L, Foulkes AS, June R, et al. (2007) Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS 21: 293-305.
53. Yonkers NL, Milkovich KA, Rodriguez B, Post AB, Asaad R, et al. (2009) Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection. Clin Immunol 131: 288-297.
54. Sacchi A, Cappelli G, Cairo C, Martino A, Sanarico N, et al. (2007) Differentiation of monocytes into CD1a- dendritic cells correlates with disease progression in HIV-infected patients. J Acquir Immune Defic Syndr 46: 519-528.
55. Buisson S, Benlahrech A, Gazzard B, Gotch F, Kelleher P, et al. (2009) Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. J Infect Dis 199: 1862-1871.
56. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, et al. (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203: 2339-2350.
57. Vitale M, Della CM, Carlomagno S, Pende D, Arico M, et al. (2005) NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571.
58. Tasca S, Tambussi G, Nozza S, Capiluppi B, Zocchi MR, et al. (2003) Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS 17: 2291-2298.